Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 62, Issue 1, 2006, Pages 32-38

  Wang, Shao Ning ^a   Deng, Yi Hui ^a   Xu, Hui ^a   Wu, Hong Bing ^a   Qiu, Ying Kun ^b   Chen, Da Wei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

Author keywords

Doxorubicin; Galactosylated lipid; Hepatocyte selective targeting; Liposomes; Parenchymal cells

Indexed keywords

(5 CHOLESTEN 3BETA YL) 4 OXO 4 [2 (LACTOBIONYLAMIDO)ETHYLAMIDO]BUTANOATE; CARBOHYDRATE DERIVATIVE; DOXORUBICIN; DRUG CARRIER; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG SYNTHESIS; DRUG TARGETING; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; LIVER CELL; LIVER PARENCHYMA; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN GLYCOSYLATION; TARGET CELL;

ALPHA-FETOPROTEINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASIALOGLYCOPROTEINS; BINDING, COMPETITIVE; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; GALACTOSIDES; HEPATOCYTES; LIPIDS; LIPOSOMES; MICE; PARTICLE SIZE;

EID: 28444449497     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2005.07.004     Document Type: Article

References (32)

1. G. Ashwell, and J. Harford Carbohydrate-specific receptors of the liver Annu. Rev. Biochem. 51 1982 531 554
2. J. Wu, M.H. Nantz, and M.A. Zern Targeting hepatocytes for drug and gene delivery: emerging novel approaches and application Front. Biosci. 7 d7 2002 17 25
3. M.A. Arangoa, N. Duzgunes, and C. Tros de Ilarduya Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin- lipoplexes Gene Ther. 10 2003 5 14
4. L.A.J.M. Sliedregt, P.C.N. Rensen, E.T. Rump, P.J. van Santbrink, M.K. Bijsterbosch, A.R.P.M. Valentijn, G.A. van der Marel, J.H. van Boom, T.J.C. van Berkel, and E.A.L. Biesen Design and synthesis of novel amphiphilic dendritic galactoside for selective targeting of liposomes to the hepatic asialoglycoprotein receptor J. Med. Chem. 42 1999 609 618
5. J. Han, S.-J. Lim, M.-.K. Lee, and C.-K. Kim Altered pharmacokinetics and liver targetability of methotrexate by conjugation with lactosylated albumins Drug Deliv. 8 2001 125 134
6. Y-H. Choi, F. Liu, J.-S. Choi, S.-W. Kim, and J.-S. Park Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA, Hum Gene Ther. 10 1999 2657 2665
7. A. Nag, and P.C. Ghosh Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver J. Drug Target. 6 1999 427 438
8. M. Yamamoto, K. Ichinose, N. Ishii, T. Khoji, K. Akiyoshi, N. Moriguchi, J. sunanoto, and T. Kanematsu Utility of liposomes coated with polysaccharide bearing 1-amino-lactose as targeting chemotherapy for AH66 hepatoma cells Oncol. Rep. 7 2000 107 111
9. S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, and M. Hashida Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice Biochim. Biophys. Acta. 1524 2000 258 265
10. C.S. Cho, K.Y. Cho, I.J. Park, S.H. Kim, T. Sasagawa, M. Uchiyama, and T. Akaike Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene J. Controlled Release 77 2001 7 15
11. R. Kassab, H. Parrot-Lopez, H. Fessi, J. Menaucourt, R. Bonaly, and J. Coulon Molecular recognition by Kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres Bioorg. Med. Chem. 10 2002 1767 1775
12. E. Ishida, C. Managit, S. Kawakami, M. Nishijawa, F. Yamashita, and M. Hashida Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice Pharm. Res. 21 2004 932 939
13. M. Hashida, K. Akamatsu, M. Nishikava, F. Yamashita, and Y. Takakura Design of polymeric prodrugs of prostaglandin E-1 having galactose residue for hepatocyte targeting J. Controlled Release 62 1999 253 262
14. R.L.A. de Vrueh, E.T. Rump, E. van de Bilt, R. van Veghel, J. Balzarini, E.A.L. Biessen, T.J.C. van Berkel, and M.K. Bijsterbosch Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: A novel therapeutic approach for hepatitis B Antimicrob. Agents Chemother. 44 2000 477 483
15. P.C.N. Rensen, L.A.J.M. Sliedregt, M. Ferns, E. Kieviet, S.M.W. van Rossenberg, S.H. van Leeuwen, T.J.C. van Berkel, and E.A.L. Biessen Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo J. Biol. Chem. 276 2001 37577 37584
16. K. Shimada, J.A. Kamps, J. Regts, K. Ikeda, T. Shiozawa, S. Hirota, and G.L. Scherphof Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethylene glycol)s Biochim. Biophys. Acta. 1326 1997 329 341
17. C.-K. Kim, K.-H. Min, Y.-K. Oh, K.-M. Park, and K.-M. Kim Preparation and lectin binding characteristics of N - stearyl lactobionamide liposomes Int. J. Pharm. 128 1996 65 71
18. S. Gao, J. Chen, X. Xu, Z. Ding, Y.-H. Yang, Z. Hua, and J. Zhang Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting Int. J. Pharm. 255 2003 57 68
19. I.-K. Park, T.-H. Kim, Y.-H. Park, B.-A. Shin, E.-S. Choi, E.-H. Chowdhury, T. Akaike, and C.-S. Cho Galatosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier J. Controlled Release 76 2001 349 362
20. D.C. Drummond, O. Meyer, K. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 742
21. H.J.M. Kempen, C. Hose, J.H. van Boom, H.H. Spanjer, J. de Lange, and A. Langendoen A water-soluble cholesteryl containing trisgalactoside: synthesis, properties, and use in directing lipid-containing particles to the liver J. Med. Chem. 27 1984 1306 1312
22. D.D. Lasic, P.M. Frederick, M.C.A. Stuart, Y. Barenholz, and T.J. McIntosh Gelation of liposome interior: A novel method for drug encapsulation FEBS Lett. 312 1992 255 258
23. S. Amselem, A. Gabizon, and Y. Barenholz Optimization and upscaling of doxorubicin-containing liposomes for clinical use J. Pharm. Sci. 79 1990 1045 1052
24. M.B. Bally, R. Nayar, D. Masin, M.J. Hope, P.R. Cullis, and L.D. Mayer Liposomes with entrapped doxorubicin exhibit extended blood residence times Biochim. Biophys. Acta. 1023 1990 133 139
25. L.D. Mayer, L.C.L. Tai, D.S.C. Ko, D. Masin, R.S. Ginsberg, P.R. Cullis, and M.B. Bally Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice Cancer Res. 49 1989 5922 5930
26. J.F. Nagelkerke, K.P. Barto, and T.J.C. van Berkel In vivo and in vitro uptake and degradation of acetylated low-density lipoprotiein by rat liver endothelial, kupffer, and parenchymal cells J. Biol. Chem. 258 1983 12221 12227
27. P.K. Gupta, and C.T. Hung Quantitative evaluation of targeted drug delivery systems Int. J. Pharm. 56 1989 217 226
28. D.T. Connolly, R.R. Townsend, K. Kawguchi, W.R. Bell, and Y.C. Lee Binding and endocytosis of cluster glycosides by rabbit hepatocytes J. Biol. Chem. 257 1982 939 945
29. S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida In vivo gene delivery to the liver using novel galactosylated cationic liposomes Pharm. Res. 17 2000 306 313
30. S. Fumoto, F. Nakadori, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver Pharm. Res. 20 2003 1452 1459
31. Y. Hattori, S. Kawakami, F. Yamashita, and M. Hashida Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting J. Controlled Release 69 2000 369 377
32. S. Kawakami, C. Munakata, S. Fumoto, F. Yamashita, and M. Hashida Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs J. Pharm. Sci. 90 2001 105 113